PUBLICATION,PATENTS & Gene Sequences Deposited

 

 Selected Research Publications in Snake venom Biochemistry and Drug Discovery from Snake venom (from 2015 onwards):

 

  1.      Kalita, B., Patra, A., Das, A., Mukherjee, A. K. (2018) Proteomic analysis and immuno-profiling of eastern India Russell’s viper (Daboia russelii) venom: Correlation between RVV composition and clinical manifestations post RV bite. Journal of Proteome Research (In press).

  2.     Kalita, B., Singh, S., Patra, A., Mukherjee, A. K. (2018) Quantitative proteomic analysis and antivenom study revealing that neurotoxic phospholipase A2 enzymes, the major toxin class of Russell’s viper venom from southern India, shows the least immuno-recognition and neutralization by commercial polyvalent antivenom. International Journal of Biological Macromolecules 118, 375-385.

  3.     Mukherjee, A. K., Saviola, A. J., Mackessy, S. P. (2018) Cellular mechanism of resistance of human colorectal adenocarcinoma cells against apoptosis-induction by Russell’s Viper venom L-amino acid oxidase (Rusvinoxidase). Biochimie 150, 8-15.

  4.     Kalita, B., Patra, A., Mukherjee, A. K. (2018) First report of the characterization of a snake venom apyrase (Ruviapyrase) from Indian Russell’s viper (Daboia russelii) venom. International Journal of Biological Macromolecules 111, 639-648.

  5.     Patra, A., Kalita, B., Chanda, A., & Mukherjee, A. K. (2017). Proteomics and antivenomics of Echis carinatus carinatus venom: Correlation with pharmacological properties and pathophysiology of envenomation. Scientific Reports7(1), 17119.

  6.    Dutta, S., Chanda, A., Kalita, B., Islam, T., Patra, A., & Mukherjee, A. K. (2017). Proteomic analysis to unravel the complex venom proteome of eastern India Naja naja: Correlation of venom composition with its biochemical and pharmacological properties. Journal of Proteomics156, 29-39.

  7.    Thakur, R., & Mukherjee, A. K. (2017). Pathophysiological significance and therapeutic applications of snake venom protease inhibitors. Toxicon, 181, 37-47.

  8.     Utkin, Y. N., Cherepakhin, I. Y., Kryukova, E. V., Shelukhina, I. V., Makarova, Y. V., Kasheverov, I. E., Mukherjee. A.K., Kuznetsov, D. V. (2017). Conjugates of α-Cobratoxin with CdSe Quantum Dots: Preparation and Biological Activity. In Nano Hybrids and Composites  13, 3-8.

  9.     Makarova, Y. V., Shelukhina, I. V., Mukherjee, A. K., Kuznetsov, D. V., Tsetlin, V. I., & Utkin, Y. N. (2017, July). Detection of human neuronalα7 nicotinic acetylcholine receptors by conjugates of snake α-neurotoxin with quantum dots. In Doklady Biochemistry and Biophysics  475, No. 1,253-255.

  10.     Kalita, B., Patra, A., & Mukherjee, A. K. (2017). Unraveling the Proteome Composition and Immuno-profiling of Western India Russell’s Viper Venom for In-Depth Understanding of Its Pharmacological Properties, Clinical Manifestations, and Effective Antivenom Treatment. Journal of Proteome Research16(2), 583-598.

  11.    Thakur, R, Kini, S., Karkulang, S., Banerjee, A., Chatterjee, P., Chanda, A., Chatterjee, A., Panda, D., Mukherjee, A. K. (2016) Mechanism of apoptosis induction in human breast cancer MCF-7 cell by Ruviprase, a small peptide from Daboia russelii russelii venom. Chemico-Biological Interactions 258, 297-304.

  12.     Mukherjee, A.K, Dutta, S., Kalita, B., Jha, D.K., Deb, P., Mackessy, S. P. (2016) Structural and functional characterization of complex formation between two Kunitz-type serine protease inhibitors from Russell’s Viper venom. Biochimie 128-12, 138-147.

  13.     Mukherjee, A.K, Kalita, B., Mackessy, S. P. (2016) A proteomics analysis of Pakistan Daboia russelii russelii venom and assessment of potency of Indian polyvalent and monovalent antivenom. Journal of  Proteomics 144, 73-86 .

  14.     Cassendra, M. M., Mukherjee, A.K., Mackessy, S. P. (2016) An analysis of venom ontogeny and prey-specific toxicity in the Monocled Cobra (Naja kaouthia). Toxicon 119, 8-20.

  15.     Saviola, A. J., Burns, P. D., Mukherjee, A. K., Mackessy, S. P. (2016) The disintegrin Tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells. International Journal of Biological Macromolecules 88, 457-464.

  16.     Mukherjee, A. K., Saviola, A. J., Burns, P.D., Mackessy, S. P. (2015) Apoptosis induction in human breast cancer (MCF-7) cells by a novel venom L-amino acid oxidase (Rusvinoxidase) is independent of its enzymatic activity and is accompanied by caspase-7 activation and reactive oxygen species production. Apoptosis 20, 1358-1372.

  17.     Thakur, R, Chattopadhyay D., Ghosh S. S., Mukherjee, A. K. (2015) Elucidation of procoagulant mechanism and pathophysiological significance of a new prothrombin activating metalloprotease purified from Daboia russelii russelii venom. Toxicon 100, 1-12.

  18.     Dutta, S., Gogoi, D, Mukherjee, A. K. (2015) Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: Inhibition of anticoagulant activity by low molecular weight heparin. Biochimie 110, 93-106.

  19.     Thakur, R, Chattopadhyay, P., Mukherjee, A. K. (2015) Biochemical and pharmacological characterization of a toxic fraction and its cytotoxin-like component isolated from Russell’s Viper (Daboia russelii russelii) venom. Comparative Biochemistry and Physiology: Part C 168, 55-65.

 Research Publications in Environmental Biotechnology and Industrial Microbiology (from 2015 onwards):

 

  1. Gogoi, D., Arora, N., Kalita, B., Sarma, R., Islam, T., Ghosh, S. S., Devi, R., Mukherjee, A. K. (2018) Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica. Nature Scientific Reports 18;8(1):6210.

  2. Bora, B., Gogoi, D., Tripathy, D., Kurkalang, S., Ramani S., Chatterjee A., Mukherjee, A. K. (2018). The N-terminal-truncated recombinant fibrin(ogen)olytic serine protease improves its functional property, demonstrates in vivo anticoagulant and plasma defibrinogenation activity as well as pre-clinical safety in rodent model, International Journal of Biological Macromolecules 111, 462-474.

  3. Mukherjee, A., Chettri, B., Langpoklakpam, J. S., Basak, P., Prasad, A., Mukherjee, A. K., Bhattacharyya, M., Singh, A.K., Chattopadhyay, D. (2017). Bioinformatic approaches including predictive metagenomic profiling reveal characteristics of bacterial response to petroleum hydrocarbon contamination in diverse environments. Scientific Reports7(1), 1108.

  4. Mukherjee, A. K., Bhagowati, P., Biswa, B. B., Chanda, A., & Kalita, B. (2017). A comparative intracellular proteomic profiling of Pseudomonas aeruginosa strain ASP-53 grown on pyrene or glucose as sole source of carbon and identification of some key enzymes of pyrene biodegradation pathway. Journal of Proteomics167, 25-35.

  5. Gogoi, D., Bhagowati, P., Gogoi, P., Bordoloi, N. K., Rafay, A., Dolui, S. K., Mukherjee, A. K. (2016) Structural and physico-chemical characterization of a dirhamnolipid biosurfactant purified from Pseudomonas aeruginosa: application of crude biosurfactant in enhanced oil recovery. RSC Advances, 6(74), 70669-70681.

  6. Bordoloi, N.K., Bhagowati, P., Chaudhuri, M.K., Mukherjee, A.K. (2016) Proteomics and Metabolomics Analyses to Elucidate the Desulfurization Pathway of Chelatococcus spPLoS One11(4), e0153547.

  7. Bora, B., Biswas, A. D., Gurung, A. B., Bhattacharjee, A., Mattaparthi, V. S. K., Mukherjee, A. K. (2017). An in silico approach to understand the structure–function properties of a serine protease (Bacifrinase) from Bacillus cereus and experimental evidence to support the interaction of Bacifrinase with fibrinogen and thrombin. Journal of Biomolecular Structure and Dynamics, 35(3), 622-644.

  8. Majumdar, S., Chattopadhyay, P., Mukherjee, A. K. (2016). In vivo anticoagulant and thrombolytic activities of a fibrinolytic serine protease (Brevithrombolase) with the k-carrageenan-induced rat tail thrombosis model. Clinical and Applied Thrombosis/Hemostasis, 22(6), 594-598..

  9. Roy, J. K., Manhar, A. K., Nath, D., Mandal, M., Mukherjee, A. K. (2015). Cloning and extracellular expression of a raw starch digesting α-amylase (Blamy-I) and its application in bioethanol production from a non-conventional source of starch. Journal of basic microbiology, 55(11), 1287-1298.

  10. Rai, S. K., & Mukherjee, A. K. (2015). Optimization for production of liquid nitrogen fertilizer from the degradation of chicken feather by iron-oxide (Fe 3 O 4) magnetic nanoparticles coupled β-keratinase. Biocatalysis and Agricultural Biotechnology, 4(4), 632-644.

  11. Majumdar, S., Dutta, S., Das, T., Chattopadhyay, P., Mukherjee, A. K. (2015) Antiplatelet and antithrombotic activity of a fibrin(ogen)olytic protease from Bacillus cereus strain FF01. International Journal of Biological Macromolecules 79, 477-489.

  12. Majumdar, S., Goswami, S., Keppen, C., Rai, S. K., Mukherjee, A. K. (2015) Statistical optimization for improved production of fibrin(ogen)olytic enzyme by Bacillus cereus strain FF01 and its in vitro thrombolytic potential assessment. Biocatalysis and Agricultural Biotechnology 4, 191-198.

    LIST OF COMPLETE  PUBLICATIONS:  

 Publication of General/Review Research Articles:

 

1. Saikia, D., Mukherjee, A. K. (2012) PLA2 enzymes: an important component of snake venom. TSI Newsletter 2 (2), 12-15.

2. Thakur, R., Mukherjee, A. K. (2012) Snake venom prothrombin activators: their importance and pathophysiological significance. TSI Newsletter 2 (2), 35-38.

3.  Majumdar, S., Mukherjee, A. K. (2012) Biomedical application of bacterial fibrinolytic protease as a new thromobolytic weapon for the coming era. TSI Newsletter 2 (2), 39-41.

4. Thakur, R., Mukherjee, A. K. (2012) Focusing on an emergent class of venom component-Thrombin inhibitors: a potential lead compound for cardiovascular drug development. TSI Newsletter 2 (1), 22-24.

5. Thakur, R., Mukherjee, A. K. (2011) Venom Therapeutics: A breakthrough in the field of medicine. TSI Newsletter1, 8-10.

6. Rai S.K., Saikia, D. and Mukherjee, A. K. (2007) Application of enzymes and microbes as molecular recognition elements (MREs) in Biosensors. In: Proceedings of Seminar on Bioelectronics, (Ed., Drs J. C. Dutta and R. Chutia), Bioelectronics Division, Dept. of Electronics and Communication Engineering, Tezpur University, Tezpur, pp: 55-56.

7. Kalita P., Tag, H., Mukhopadhyay, P. K., Das, A. K. and Mukherjee, A. K. (2005) Indigenous fishing techniques practiced by the tribes of Arunachal Pradesh (north east India). Aquaculture Asia 2, 35-37 (Published from Aquaculture society of Asia, Bangkok, Thailand).

8. Mukherjee, A. K., Maity, C.R., Bhattacharyya, B (1995) G Proteins-intermediate in signal transduction: a tribute to Rodbell and Gilman. In: Proceedings of the IV the National Conference of the Association of Medical Biochemists of India, (Ed., Prof. C.R. Maity), BurdwanUniversity, Burdwan, pp: 77-84.

9. Mukherjee, A. K (1994) Oncogene targeted antisense oligonucleotides-a novel approach to the problem of oncogenesis. Everyman's Science XXIX, 106-108.

 

 Publication of Book Chapters:

 

1. Mukherjee, A. K. (2000) Biotechnology in health care: challenges and promises for us in the next millennium. In: Indian Chemical Industry-Opportunities Unlimited. Published by Dept. of Chemicals and Petrochemicals, Govt. of India, pp: 173-176.

2. Doley, R., Mukherjee, A. K. (2003)`Pharmacological assessment of medicinal plants to ascertain their anti-snake venom activity. In: Ethnomedicine of North-East India: Protection, Utilization and Conservation. (Singh, G, Singh, H.B. and Mukherjee, T.K. Editors), National Institute of Science Communication and Information Resources, CSIR, New Delhi, pp: 300-304.

3. Mukherjee, A. K., Das, K. (2010) Microbial Surfactants and their Potential Applications: An Overview. In: Biosurfactants (Sen, R. K., Editor), Landes Bioscience, Texas, USA.

4. Mukherjee, A. K. (2013) An updated inventory on properties, pathophysiology and therapeutic potential of snake venom thrombin-like proteases. In: S. Chakraborti, N.S. Dhalla, (Eds.), Proteases in Health and Disease-Advances in Biochemistry in Health and Disease  Volume 7 (ISBN 978-1-4614-9233-7), Springer, pp.163-180.

5. Thakur, R., Mukherjee, A. K. (2016) A Brief Appraisal on Russell’s Viper Venom (Daboia russelii) Proteinases. In: Handbook on Toxinology, Volume Snake Venom (Mukherjee, AK, Rhamy TA. Editors), Springer, Singapore (in press).

6. Saikia, D., Mukherjee, A. K. (2016) Anticoagulant and membrane damaging properties of snake venom phospholipase A2 enzymes. In: Handbook on Toxinology, Volume Snake Venom (Mukherjee, AK, Rhamy TA. Editors), Springer, Singapore (in press).

7. Thakur R, and Mukherjee, A. K. (2016) Pathophysiological significance and therapeutic implications of Russell’s viper proteins and peptides effecting blood coagulation.  Invited article submitted in Snake Venoms and Envenomation: Modern Trends and Future Prospects (Utkin, Y. editor), Nova Science Publishers, INC. USA.

8. Utkin,Y. N., Cherepakhin, I. Y., Kryukova,E. V., Shelukhina, I. V., Makarova,Y. V.,Kasheverov, I. E., Mukherjee,A. K., Gusev, A. A., Kuznetsov D. V.(2017). Conjugates of α-Cobratoxin with CdSe Quantum Dots: Preparation and Biological Activity. In: Nano Hybrids and Composites (A. Gusev, T. Dyatcheck and A. Godymchuk, Eds), Vol. 13, pp. 3-8, DOI: 10.4028/www.scientific.net/NHC.13.3 (online book chapter).

  International & National Patent Granted and APPLIED:

International Patents:

  1. US patent on "Acaricidal compositions and methods of use thereof". United States patent No.: US 7,575,758 B2; filing date: 13.09.2006; Publication date: August 2009

  2. International patent on "Acaricidal compositions and methods of use      thereof". International patent publication No. WO/2007/035382, dated 29 March, 2007

  3. European Patent on Acaricidal compositions and methods of use thereof" Patent No. EP1924599 (A2); filing date: 13.9.2006; Publication date 28 May, 2008

  4. PCT International Application on “ANTICOAGULANT ACTIVITIES AND SYNERGISTIC ANTICOAGULANT COMPOSITION AND METHOD FOR PRODUCING THE SAME" application No. PCT/IN2016/050448 dated 17.12.2016

Indian Patents:

  1. Indian Patent on "Anticoagulant activities and synergistic anticoagulant composition and method for the same" Patent No. 13/3/KOL/2015; filing date: 18.12.2015

  2. Indian Patent on “SYNTHETIC ANTICOAGULANT PEPTIDES DERIVED FROM NAJA NAJA SNAKE VENOM PATENT APPLICATION NO. 201831010001; Filling date: 19 March, 2018

  3. Indian Patent on “TOXIN EPITOPE-BASED DETECTION OF SPECIES-SPECIFIC SNAKE         ENVENOMATION PATENT APPLICATION NO. 201831010002; Filling date: 19 March, 2018

   Details of Proteome submitted to public domain:

 

S.No

Source

Project name

Dataset identifier

Data bank

1

Echis carinatus venom

Echis carinatus carinatus (India) venom proteomics

PXD007980

ProteomeXchange Consortium (via the PRIDE)

2

Naja naja venom

Venom proteomics of Naja naja of western India origin

PXD008011

 

ProteomeXchange Consortium (via the PRIDE)

3

Daboia russelli venom

Proteomic analysis of Daboia russelli venom
samples from eastern India

PXD008607

ProteomeXchange Consortium (via the PRIDE)

 

   Details of 16S Nucleotide sequence submitted to GenBank:

 

S.No

Name of  bacterial strain

Amplified Gene

Gene Bank Id No

Enzyme producer

1.

Brevibacillus sp. AS-S10-II

16S ribosomal RNA gene, partial sequence,

GU332637

Alkaline β-keratinase (Brevicarnase)

2.

Bacillus sp. AS-S20-I

16S ribosomal RNA gene, partial sequence,

GU001817

Fibrinolytic protease

3.

Bacillus licheniformis strain AS-S24-I

16S ribosomal RNA gene, partial sequence,

GU269542

Alkaline β-keratinase (Alkarnase)

4.

Paenibacillus sp. AS-S24-II

16S ribosomal RNA gene, partial sequence,

FJ804507

Detergent stable alkaline protease

5.

Bacillus sp. AS-S01a

16S ribosomal RNA gene, partial sequence,

FJ887877

Detergent stable alkaline α-amylase

6

Chelatococcus sp. NBTU-06

16S-rRNA gene, partial sequence, Delhi University

JN034906

Biodesulfurizing agent

7

Achromobacter sp. NBTU-02

16S ribosomal RNA gene, partial sequence

JN034907

-do-

8

Bacillus sp. AS-S01a

16S-23S ribosomal RNA intergenic spacer, complete sequence

JN118575

Alkaline α-amylase

9

Bacillus sp. AS-S01a

gyrase A (gyrA) gene, partial

JN133844

-do-

10

Bacillus sp. AS-S01a

RNA polymerase beta subunit (rpoB) gene, partial 

JN133845

-do-

11

Bacillus sp. AS-S08E

16S ribosomal RNA gene, partial sequence

JN118574

-do-

12

Bacillus sp. AS-S08E

16S-23S ribosomal RNA intergenic spacer,

JN133843

-do-

13

Bacillus sp. AS-S08E

gyrase A (gyrA) gene, partial

JN133841

-do-

14

Bacillus sp. AS-S08E

RNA polymerase beta subunit (rpoB) gene, partial 

JN133842

-do-

15

Bacillus sp. AS-S01a

Alpha-amylase complete CDS

KC113313

Acidic amylase

16

Bacillus sp. AS-S08E

Alpha-amylase complete CDS

KC802019

Alkaline α-amylase

17

Pseudomonas sp. NBTU-01

16S ribosomal RNA gene, partial sequence

JQ241432

Biosurfactant producer

18

Chelatococcus sp. NBTU-06

Desulfurization gene DszA

KJ395107

Desulfurization enzyme (DszA)

19

Chelatococcus sp. NBTU-06

Desulfurization gene DszB

KJ395108

Desulfurization enzyme (DszB)

20

Chelatococcus sp. NBTU-06

Desulfurization gene DszC

KJ395109

Desulfurization enzyme (DszC)

21

Bacillus cereus strain FF01

16SrDNA partial sequence

KC992322

Fibrinolytic enzyme

22

Bacillus cereus strain AB01

Serine protease gene

KM502865.1

Protease enzyme

23 Bacillus cereus strain AB01 16SrRNA KP7946162 Protease enzyme

 

 Seminar / Conference paper Presentation (2015 onwards):

 

Sl. No.

 Names of all the authors (as they appear in each paper)

 

Title of the paper

 

Name of the Conference, place, and year

  1

Mukherjee, A.K., Dutta, S.  Kalita, B., Mackessy, S. P.

 

Potential biomedical application of Kunitz-type protease inhibitors from Daboia russelii russelii venom

 

18th World Congress of International Society on Toxinology, Oxford, UK from 25-30 September, 2015

 2

Mukherjee, A.K.

 

Mechanism of apoptosis induction in human breast cancer (MCF-7) cells by an L-amino acid oxidase (LAAO) purified from Russell’s Viper (Daboia russelii russelii) venom

 

TSICON-15, 5th  National Conference on Toxinological Society of India, Organized by Little Flower Hospital, Cochin 21-22 November, 2015

  3

Thakur, R.,  Chattopadhyay, P., Mukherjee, A.K.

 

A new prothrombin activator from Indian Russell’s viper (Daboia russelii russelii) venom: characterization and pathophysiological significance

 

TSICON-15, 5th National Conference on Toxinological Society of India, Organized by Little Flower Hospital, Cochin 21-22 November, 2015

  4

Mukherjee, A.K.

 

Microbial Anticoagulant Proteases for the Prevention and/or Treatment of Cardiovascular Disorders

 

 

Recent Developments in Medical Biotechnology and Structure Based Drug Designing [RDMBSBDD-2015] organized by IIT, Guwahati, 6-7 December, 2015

  5

Mukherjee, A.K.

 

Assessment of Therapeutic Potential of Microbial fibrin(ogen)olytic Serine Proteases for the Treatment of Cardiovascular Disorders

 

Medical (including Physiology) section, 103rd Indian Science Congress, Mysore University, 3-7 January, 2016

  6

Mukherjee, A.K. , Dutta, S., ,Kalita, B., Jha, D. K., Deb, P.

 

Characterization of Rusvikunin complex isolated from Daboia russelii russelii venom to comprehend its potent biological activity

 

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

  7

Saikia, D., Mukherjee, A.K.

 

Biochemical and pharmacological characterization of a neutral PLA2 enzyme from Daboia russelii venom and inhibition of its enzymatic activity and invitro pharmacological property by Azadirachta indica and Xanthium strumerium leave extracts

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

  8

Thakur, R., Chanda, A., Kumar, A., Kini, S., Karkulang, S., Banerjee, A., Chatterjee, P., Bose, B., Chatterjee, A., Panda, D., Chattopadhyay, P.,  Mukherjee, A.K.

 

Elucidating the anticoagulant property and anticancer potential of a small peptide purified from Daboia russelii russelii venom

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

  9

Dutta, S., Chanda, A.,  Kalita, B., Islam, T., Patra, A., Mukherjee, A.K.

 

Proteomic, biochemical and pharmacological characterization of eastern India Naja naja venom and correlation of these properties with clinical manifestation of cobra bite

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

  10

Kalita, B., Patra, A., Mukherjee, A.K.

 

Exploring the venom proteome of Daboia russelii from western India: Correlation between RVV composition and its clinical manifestations

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

  11

Islam, T., Mazumder, M.,  Mukhopadhaya, R., Utkin, Y.N., Mukherjee, A.K.

 

Purification and characterization of nerve growth factor (NGF) isoforms from Western India Russell`s Viper (Daboia russelii russelii) venom

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

 12

Chanda, A.,  Islam, T., Patra, A., Kalita, B.,  Dutta, S., Mukherjee, A.K.

 

Assessment of efficacy of three Indian polyvalent antivenoms against Eastern and Western India Naja naja venom

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

 13

Patra, A., Kalita, B., Mukherjee, A.K.

 

Studies on neutralization of biochemical and pharmacological properties and antivenomics of Indian polyvalent and monovalent antivenom against Western India Russell’s viper (Daboia russelii) venom

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

 14

Das, A., Ramani, S., Dutta, S., Gogoi, D., Bora, B., Mukherjee, A.K.

 

Cardiovascular drug development from snake venom: Fact or fiction?

 

Recent Advances in Snakebite Research and Snakebite Therapy: National and International Perspective: SnakSymp2016, Tezpur University, 22-24 November, 2016

 15

Mukherjee, A.K.

 

Venomics and antivenomics of Russell’s Viper (Daboia russelii)- A major venomous snake in Indian subcontinent

 

New Biology section, 104th Indian Science Congress, S. V. Tirupati University, 3-7 January, 2017

 16

Mukherjee, A.K.

 

Proteomics approach to reveal the polyromantic hydrocarbons degradation pathways operate in hydrocarbon degrading bacteria with a specific example of Pseudomonas aeruginosa

 

Petroleum Biotechnology and Bioenergy, ONGC-Center for Petroleum Biotechnology and Department of Energy, Tezpur University, 3-4 March, 2017

 17

Mukherjee, A.K., Islam, T., Utkin Y.N.

 

Application of snake venom nerve growth factor labelled with functionalized nanoparticles for the detection of cancer

 

3rd International Conference on Translational Research: Application in Human Health and Agriculture. Organized by Indian Society of Translational Research, Amity University, Kolkata, 22-25 September, 2017

 18

Mukherjee, A.K.

 

Strategies for therapeutic application and commercialization of traditional medicinal plants used against snakebite

 

One day workshop on  Translational Research on Natural Products for Therapeutic Uses, IASST, Guwahati, 21 November, 2017

 19

Mukherjee, A.K.

 

Career Opportunities and Job Prospects in Biotechnology Teaching & Research:
Unprecedented Growth Opportunity
 

 

DBT Biotech Hub sponsored Workshop on Basic Tools and Techniques in Molecular Biology and its Applications organized by Department of Biotechnology, Darrang College, Tezpur, 1-3 November, 2017

 20

Mukherjee, A. K.

 

Cardiovascular Drug Development from Indian Snake Venom:  Prospects and Challenges

 

Continuing Education programme, Defense Research Laboratory, Tezpur, 8 November, 2017

 21

Mukherjee, A. K., Patra, A., Kalita, B., Chanda, A.

 

Studies on venom proteome composition of Indian Saw-scaled viper (Echis carinatus) and cross-reactivity of venom proteins with commercial polyvalent antivenom

 

SnakSymp: National Seminar on Snake Venom Research and Snake-bite Therapy, CCMB, Hyderabad, 30 November-3 December, 2017

22

Mukherjee, A. K.

 

Venomics and antivenomics of Indian cobra Naja naja venom: Failure to immuno-recognition of low molecular mass venom proteins by commercial polyvalent antivenom

 

Trends in Biochemical and Biomedical Research: Advances and Challenges, Department of Biochemistry, Banaras Hindu University, Varanasi, February 13-15, 2018

23

Mukherjee, A. K.

 

Green medicine for snakebite: From therapeutic applications to conservation strategies

 

National Conference on Drug Discovery from Natural Products and their Traditional Uses, University of Science and Technology, Meghalaya, March 23-24, 2018

24

Mukherjee, A. K.

 

Assessment of Quality of Antivenom for Efficient Hospital Management of Snakebite

 

National Conference on Recent Advances on Applied Biological Sciences, Department of Biotechnology and Bioinformatics, North Eastern Hill University, Shillong, 4-5 May, 2018

    LIST OF PREVIOUS SEMINAR/PRESENTATION:  

 

HOME